SynthesisFrontiers in medicine2026
Association between obstructive sleep apnea syndrome and blood pressure variability: a meta-analysis.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obstructive sleep apnea syndrome (OSAS) is associated with increased cardiovascular risk, but its relationship with blood pressure variability (BPV), an independent predictor of adverse outcomes, remains incompletely defined. This meta-analysis aimed to evaluate the association between OSAS and BPV assessed by ambulatory blood pressure monitoring (ABPM). Methods: PubMed, Embase, Web of Science, Wanfang, and CNKI were systematically searched for observational studies comparing BPV between adults with OSAS and non-OSAS controls. BPV was evaluated based on standard deviation of systolic (SBP) and diastolic blood pressure (DBP) derived from 24-h ABPM, including nighttime, daytime, and 24-h periods, as reported in the original studies. Random-effects models were used to pool mean differences (MDs) with 95% confidence intervals (CIs). Results: Eleven studies comprising 17 datasets (1,261 patients with OSAS and 826 controls) were included. Compared with controls, OSAS was associated with significantly higher BPV across all periods. Nighttime BPV showed the largest differences (SBP: MD 1.89 mmHg, 95% CI 1.07-2.70; DBP: MD 1.93 mmHg, 95% CI 1.17-2.69), followed by 24-h BPV (SBP: MD 1.77 mmHg, 95% CI 0.80-2.75; DBP: MD 1.17 mmHg, 95% CI 0.47-1.87) and daytime BPV (SBP: MD 1.17 mmHg, 95% CI 0.35-1.99; DBP: MD 0.61 mmHg, 95% CI 0.26-0.96). Subgroup analyses suggested a trend toward increasing BPV with greater OSAS severity, with statistically significant differences observed only for nighttime DBP variability ( Conclusion: OSAS is associated with increased BPV, particularly during nighttime. Although a trend toward greater BPV with increasing OSAS severity was observed, the certainty of evidence ranged from low to very low, and substantial between-study heterogeneity warrants cautious interpretation of the findings. Systematic review registration: CRD420261395221.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.